Related Experiment Video
Updated: Dec 17, 2025

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
Published on: September 26, 2012
Glycine Receptor Autoantibodies Impair Receptor Function and Induce Motor Dysfunction
Vera Rauschenberger1, Niels von Wardenburg1, Natascha Schaefer1
1Institute for Clinical Neurobiology, University Hospital, Julius Maximilian University of Würzburg, Würzburg, Germany.
Autoantibodies targeting glycine receptors impair neurotransmission, causing movement disorders like stiff-person syndrome. In vivo studies confirm these autoantibodies directly cause disease phenotypes in a zebrafish model.
Area of Science:
- Neuroimmunology
- Molecular Neuroscience
- Autoimmune Disorders
Background:
- Glycinergic neurotransmission is crucial for motor control.
- Autoantibodies against glycine receptors are implicated in stiff-person syndrome and related disorders.
- The precise mechanisms of glycine receptor dysfunction due to autoantibodies are not fully understood.
Purpose of the Study:
- To investigate the functional consequences of glycine receptor autoantibodies.
- To identify the epitope targeted by these autoantibodies.
- To establish a causal link between autoantibodies and disease phenotypes in vivo.
Main Methods:
- Electrophysiological recordings and radioligand binding assays to assess receptor function.
- Cell-based assays for sample evaluation.
- In vivo passive transfer of patient autoantibodies into zebrafish larvae.
Main Results:
- Patient autoantibodies significantly reduced glycine receptor potency.
- A common epitope on the N-terminal domain (residues 29-62) was identified.
- In vivo transfer induced impaired motor behavior and reduced spinal cord glycine receptor clusters in zebrafish.
Conclusions:
- Autoantibodies targeting the extracellular domain of glycine receptors alter receptor physiology.
- In vivo data demonstrate that these autoantibodies are a direct cause of disease phenotypes.
- Findings support a causal role for glycine receptor autoantibodies in stiff-person syndrome and related conditions.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Drugs Acting on Autonomic Ganglia: Blockers

